N-(3-chlorophenyl)-4-(2-chloropyridin-4-yl)pyrimidin-2-amine, 98%, 100mg

5-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid, 100mg

1,16-HEXADECANEDIOL, 95.0%, 25g

5-(Difluoromethoxy)-2-mercaptobenzimidazole>98.0%(HPLC)(T)25g

5-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, 95.0%, 1g

TRANS-METHYL 4-ACETYLCYCLOHEXANECARBOXYLATE, 95.0%, 500mg

Ácido ftálico, mínimo 99%, pa, 1 kg, envase de plástico.

5-Bromo-4-cyanopyrimidine, 95.0%, 5g

2-(1-(Prop-2-yn-1-yl)piperidin-4-yl)acetic acid, 95%, 2.5g

3-Azabicyclo[3.1.0]hexane-1,3-dicarboxylic acid, 3-(1,1-dimethylethyl) ester, (1R,5R)-, 97%, 100mg

(4R,4'R)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 5g

5-bromo-1-isopropyl-1H-pyrazole, 95.0%, 100mg

(3,3,3-Trifluoropropyl)dimethylmethoxysilane, 1g